These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 16631754)

  • 21. Apocrine carcinoma of the breast presenting as a solitary cyst: cytological and histopathological study of a case.
    Mardi K; Sharma J; Sharma N
    Indian J Pathol Microbiol; 2004 Apr; 47(2):268-70. PubMed ID: 16295496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solid apocrine carcinoma of the skin: report of a rare adnexal neoplasm mimicking lobular breast carcinoma.
    Zelger BG; Stelzmueller I; Dunst KM; Zelger B
    J Cutan Pathol; 2008 Mar; 35(3):332-6. PubMed ID: 18251751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
    Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
    Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apocrine adenoma of the breast.
    Cashell AW
    W V Med J; 2008; 104(2):16-9. PubMed ID: 18491794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroendocrine carcinomas of the breast.
    Rovera F; Masciocchi P; Coglitore A; La Rosa S; Dionigi G; Marelli M; Boni L; Dionigi R
    Int J Surg; 2008; 6 Suppl 1():S113-5. PubMed ID: 19167937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benign and malignant apocrine lesions of the breast.
    Gerhard R; Costa JL; Schmitt F
    Expert Rev Anticancer Ther; 2012 Feb; 12(2):215-21. PubMed ID: 22316369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
    de Candia P; Akram M; Benezra R; Brogi E
    Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-operative breast pathology: apocrine lesions.
    Wells CA; El-Ayat GA
    J Clin Pathol; 2007 Dec; 60(12):1313-20. PubMed ID: 18042688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. STAT 5a expression in the breast is maintained in secretory carcinoma, in contrast to other histologic types.
    Strauss BL; Bratthauer GL; Tavassoli FA
    Hum Pathol; 2006 May; 37(5):586-92. PubMed ID: 16647957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vulvar apocrine adenocarcinoma: a case with nodal metastasis and intranodal mucinous differentiation.
    Alsaad KO; Obaidat N; Dube V; Chapman W; Ghazarian D
    Pathol Res Pract; 2009; 205(2):131-5. PubMed ID: 18842349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclin D-1 protein over-expression is not associated with gene amplification in benign and atypical apocrine lesions of the breast.
    Elayat G; Selim AG; Gorman P; Tomlinson I; Wells CA
    Pathol Res Pract; 2011 Feb; 207(2):75-8. PubMed ID: 21159451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Invasive apocrine carcinoma of the breast: clinicopathologic features of 57 patients.
    Tanaka K; Imoto S; Wada N; Sakemura N; Hasebe K
    Breast J; 2008; 14(2):164-8. PubMed ID: 18248561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer.
    Borgquist S; Jögi A; Pontén F; Rydén L; Brennan DJ; Jirström K
    Breast Cancer Res; 2008; 10(5):R79. PubMed ID: 18808688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Classification and grading of invasive breast carcinoma.
    Elston CW
    Verh Dtsch Ges Pathol; 2005; 89():35-44. PubMed ID: 18035670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apocrine carcinoma of the breast: a comprehensive review.
    Vranic S; Schmitt F; Sapino A; Costa JL; Reddy S; Castro M; Gatalica Z
    Histol Histopathol; 2013 Nov; 28(11):1393-409. PubMed ID: 23771415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical relevance of the distribution of the lesions in 500 consecutive breast cancer cases documented in large-format histologic sections.
    Tot T
    Cancer; 2007 Dec; 110(11):2551-60. PubMed ID: 17932896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential expression of glucocorticoid receptor in human breast tissues and related neoplasms.
    Lien HC; Lu YS; Cheng AL; Chang WC; Jeng YM; Kuo YH; Huang CS; Chang KJ; Yao YT
    J Pathol; 2006 Jul; 209(3):317-27. PubMed ID: 16639692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IMP3, a proposed novel basal phenotype marker, is commonly overexpressed in adenoid cystic carcinomas but not in apocrine carcinomas of the breast.
    Vranic S; Gurjeva O; Frkovic-Grazio S; Palazzo J; Tawfik O; Gatalica Z
    Appl Immunohistochem Mol Morphol; 2011 Oct; 19(5):413-6. PubMed ID: 21436679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Should histologic type be taken into account when considering neoadjuvant chemotherapy in breast carcinoma?
    Sullivan PS; Apple SK
    Breast J; 2009; 15(2):146-54. PubMed ID: 19292800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 'Pure' invasive apocrine carcinoma of the breast: a new clinicopathological entity?
    Japaze H; Emina J; Diaz C; Schwam RJ; Gercovich N; Demonty G; Morgenfeld E; Rivarola E; Gil Deza E; Gercovich FG
    Breast; 2005 Feb; 14(1):3-10. PubMed ID: 15695074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.